Literature DB >> 7678109

Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.

M W Pride1, A Thakur, Y Thanavala.   

Abstract

B and T cell responses of several strains of mice, immunized with a monoclonal antiidiotype (anti-Id) that mimics the a determinant of hepatitis B surface antigen (HBsAg), were studied to determine if the immune response to the anti-Id was regulated by H-2-linked immune response genes as has been previously observed for HBsAg. We report that immunization with anti-Id could elicit HBsAg-specific antibodies in mice of the H-2d,q, or f haplotype and in an outbred wild mouse strain (Mus spretus), thus circumventing the H-2 haplotype restriction pattern observed when immunizing with HBsAg in H-2f mice. Purified lymph node T cells from mice of the H-2d or q haplotype and M. spretus that were primed in vivo with HBsAg or anti-Id could be stimulated in vitro with either HBsAg or anti-Id but not with an irrelevant antibody of the same subclass as the anti-Id. However, purified lymph node T cells from H-2f mice that were primed in vivo with the anti-Id could only be stimulated in vitro with anti-Id. No in vitro stimulation whatsoever was observed in H-2f mice immunized with HBsAg. The effect of processing and presentation of the anti-Id by antigen-presenting cells (APC) was studied in mice of the H-2d haplotype. Stimulation of purified lymph node T cells by HBsAg and anti-Id was shown to be strictly dependent on APC and restricted by major histocompatibility complex class II antigens at the I-A locus. Treatment of APC with paraformaldehyde or chloroquine abrogated the T cell response to all antigens except for a nine-amino acid synthetic peptide representing a partial analogue of the group a determinant of HBsAg S(139-147). The significance of these results is discussed in the context of understanding the mechanism of mimicry elicited by the anti-Id.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678109      PMCID: PMC2190873          DOI: 10.1084/jem.177.1.127

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  T-cell dependence of immune response to hepatitis B antigen in mice.

Authors:  I M Roberts; C C Bernard; G N Vyas; I R Mackay
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

2.  The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.

Authors:  Z Kovac; R H Schwartz
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

3.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.

Authors:  D R Milich; D L Peterson; G G Leroux-Roels; R A Lerner; F V Chisari
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  The structural requirements for class II (I-Ad)-restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes.

Authors:  C M Graham; B C Barnett; I Hartlmayr; D S Burt; R Faulkes; J J Skehel; D B Thomas
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

5.  Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies.

Authors:  R S Tedder; P Guarascio; J L Yao; R B Lord; A L Eddleston
Journal:  J Hyg (Lond)       Date:  1983-02

6.  Mechanism of T lymphocyte activation by OKT3 antibodies. A general model for T cell induction.

Authors:  U Landegren; J Andersson; H Wigzell
Journal:  Eur J Immunol       Date:  1984-04       Impact factor: 5.532

7.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.

Authors:  D R Milich; R E Louie; F V Chisari
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; H J Alter; P E Taylor; A DeVera; G T Chen; A Kellner
Journal:  N Engl J Med       Date:  1982-12-09       Impact factor: 91.245

10.  Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus.

Authors:  A H Sharpe; G N Gaulton; K K McDade; B N Fields; M I Greene
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  7 in total

1.  Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody.

Authors:  J Vani; R Nayak; M S Shaila
Journal:  Immunology       Date:  2007-01-11       Impact factor: 7.397

2.  Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

Authors:  Y Thanavala; Y F Yang; P Lyons; H S Mason; C Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

3.  Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide.

Authors:  M Rajadhyaksha; Y Thanavala
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Anti-idiotypic antibody production in hepatitis B vaccine recipients.

Authors:  K Kobayashi; Y Ueno; H Suzuki; M Miura; R Nagatomi; M Ishii; T Toyota
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

5.  Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers.

Authors:  Lemonica Koumbi; Antonio Bertoletti; Vassiliki Anastasiadou; Maria Machaira; Winnie Goh; Nikolaos G Papadopoulos; Dimitris A Kafetzis; Vassiliki Papaevangelou
Journal:  Cell Mol Immunol       Date:  2010-07-26       Impact factor: 11.530

6.  Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.

Authors:  L Brossay; A Villeneuve; G Paradis; L Coté; W Mourad; J Hébert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.

Authors:  J Fagerberg; M Steinitz; H Wigzell; P Askelöf; H Mellstedt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.